Clinical Trials Browser

Phase 1/2 × Neuroendocrine Tumors × 90 days × Clear all

Neoplasm Metastasis, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06055439 2026-01-29

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Phase 1/2 Recruiting

135 enrolled

EndocrineGastrointestinalNET

Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

Clinical Trials

BRAVESST2

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy